Avalo Therapeutics Inc (AVTX) — Capital Reinvestment Ratio
Avalo Therapeutics Inc (AVTX) has a Capital Reinvestment Ratio of 0.01x as of September 2022, meaning it reinvests 0% of its operating cash flow ($5.73 Million) in capital expenditures ($39.00K). See AVTX net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Avalo Therapeutics Inc Capital Reinvestment Ratio (2017–2017)
This chart tracks Avalo Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check AVTX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Avalo Therapeutics Inc (2017–2017)
Year-by-year Capital Reinvestment Ratio for Avalo Therapeutics Inc from 2017 to 2017. For live market cap and broader valuation context, see AVTX stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.00x | $12.52 Million | $23.32K | — |